Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional outcomes after minor ...

(HealthDay News) — Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within one year, with higher discontinuation rates seen for those ...

Most of us are aware that excess weight around the belly in middle age raises our risk of developing a long list of health ...

Yes, weightloss drugs can help you lose weight – but they can also boost your health in unexpected ways. Good Housekeeping’s ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.

When it comes to achieving healthy body weight, some men might look to what’s average and use that as their goal. For ...

Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest ...

A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed ...

KATIE Price’s 28 stone son faces more surgery after going on Ozempic jabs. And Harvey’s terrified mum fears the 22-year-old may die of a heart attack without help. Coming soon: Katie ...